SILVERSTEIN JONATHAN

CIK 000117100512 companiesLAWRENCE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001171005

Recent Transactions

50 trades

Purchase
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-10-02$25.00/sh+296,000→ 902,286 total
Purchase
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-10-02$25.00/sh+200,000→ 4,267,564 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2020-06-03+14,414→ 14,414 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2020-02-27+24,000→ 24,000 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Series C Preferred Stock
2020-02-04−859,573→ 0 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-04+429,786→ 606,286 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Series C Preferred Stock
2020-02-04−429,786→ 0 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Series B Preferred Stock
2020-02-04−2,825,603→ 0 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-04+2,825,603→ 3,207,991 total
Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-04+859,573→ 4,067,564 total
Purchase
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-03$17.00/sh+176,500→ 176,500 total
Purchase
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2020-02-03$17.00/sh+382,388→ 382,388 total
Disposition to Issuer
AVEDRO INC
Stock Option (right to buy)
2019-11-21−8,314→ 0 total
Disposition to Issuer
AVEDRO INC
Restricted Stock Units
2019-11-21−3,005→ 0 total
Disposition to Issuer
AVEDRO INC
Common Stock
2019-11-21−4,240,128→ 0 total
Award
AVEDRO INC
Restricted Stock Units
2019-06-14+3,005→ 3,005 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2019-05-08+14,414→ 14,414 total
Conversion
AVEDRO INC
Common Stock
2019-02-19+383,746→ 4,240,128 total
Conversion
AVEDRO INC
Common Stock
2019-02-19+333,178→ 3,856,382 total
Conversion
AVEDRO INC
Series BB Convertible Preferred Stock
2019-02-19−333,178→ 0 total
Conversion
AVEDRO INC
Common Stock
2019-02-19+3,370,786→ 3,523,204 total
Conversion
AVEDRO INC
Series AA Convertible Preferred Stock
2019-02-19−3,370,786→ 0 total
Conversion
AVEDRO INC
Series CC Convertible Preferred Stock
2019-02-19−383,746→ 0 total
Award
AVEDRO INC
Stock Option (right to buy)
2019-02-19+8,314→ 8,314 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-06$32.06/sh−46,676→ 0 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-06$30.77/sh−192→ 445 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-06$30.77/sh−20,114→ 46,676 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-06$30.01/sh−93,008→ 66,790 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-06$32.06/sh−445→ 0 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-06$30.01/sh−886→ 637 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-05$33.06/sh−768→ 1,523 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-05$33.06/sh−80,516→ 159,798 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-05$32.05/sh−128,092→ 240,314 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-05$32.05/sh−1,220→ 2,291 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-02$32.80/sh−1,851→ 3,511 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-02$32.80/sh−194,433→ 368,406 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-02$31.92/sh−2,533→ 5,362 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2018-03-02$31.92/sh−265,766→ 562,839 total
Conversion
Adicet Bio, Inc.$ACET
Series A Preferred Stock
2018-01-30−2,425,482→ 0 total
Conversion
Adicet Bio, Inc.$ACET
Common Stock
2018-01-30+1,871,569→ 4,297,054 total
Conversion
Adicet Bio, Inc.$ACET
Common Stock
2018-01-30+2,425,485→ 2,425,485 total
Conversion
Adicet Bio, Inc.$ACET
Series B Preferred Stock
2018-01-30−1,871,569→ 0 total
Purchase
Adicet Bio, Inc.$ACET
Common Stock
2018-01-30$15.00/sh+533,333→ 4,830,387 total
Award
GLAUKOS Corp$GKOS
Stock option (right to buy)
2017-12-13+15,000→ 15,000 total
Conversion
scPharmaceuticals Inc.$SCPH
Common Stock
2017-11-21+2,576,532→ 2,576,532 total
Conversion
scPharmaceuticals Inc.$SCPH
Series B Preferred Stock
2017-11-21−18,500,000→ 0 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2017-09-05$40.77/sh−58,047→ 828,605 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2017-09-05$37.94/sh−173,349→ 1,076,444 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2017-09-05$39.63/sh−189,792→ 886,652 total
Sale
GLAUKOS Corp$GKOS
Common Stock, par value $0.01 per share
2017-09-05$37.94/sh−1,651→ 10,256 total

Companies

Recent Filings

Address

C/O NXSTAGE MEDICAL, INC. 439 SOUTH UNION STREET, 5TH FLOOR

LAWRENCE, MA, 01843

View on SEC.gov